DOI: 10.1007/bf00685951. Pharmacokinetics of high-dose etoposide after short-term infusion

Pharmacokinetics of high-dose etoposide after short-term infusion

10.1007/bf00685951

Crossref journal-article

Springer Science and Business Media LLC

Cancer Chemotherapy and Pharmacology (297)

Bibliography

Kï¿½hl, P., Kï¿½ppler, H., Schmidt, L., Fritsch, H. W., Holz, J., Pflï¿½ger, K. H., & Jungclas, H. (1992). Pharmacokinetics of high-dose etoposide after short-term infusion. Cancer Chemotherapy and Pharmacology, 29(4), 316â320.

Authors 7

P. K�hl (first)
H. K�ppler (additional)
L. Schmidt (additional)
H. W. Fritsch (additional)
J. Holz (additional)
K. H. Pfl�ger (additional)
H. Jungclas (additional)

References 25 Referenced 16

Blume KG, Forman SJ, O'Donell MR, Doroshow JH, Krance RA, Nademanee AP, Snyder DS, Schmidt GM, Fahey JL, Metter GE, Hill LR, Findley DO, Sniecinski IJ (1987) Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood 69:1015 (10.1182/blood.V69.4.1015.1015) / Blood by KG Blume (1987)
Burnett AK, Watkins R, Maharaj D (1984) Transplantation of unpurged autologous bone marrow in acute myeloid leukemia in first remission. Lancet 11:1068 (10.1016/S0140-6736(84)91508-3) / Lancet by AK Burnett (1984)
Cunningham D, Cummings J, Blackie RB, McTaggart L, Banham SW, Kaye SB, Soukop M (1987) The pharmacokinetics of high dose cyclophosphamide and high dose etoposide. Med Oncol Tumor Pharmacother 5:117 (10.1007/BF02985449) / Med Oncol Tumor Pharmacother by D Cunningham (1987)
Danigel H, Pflüger KH, Jungclas H, Schmidt L, Dellbrügge J (1985) A combined method of liquid chromatography and mass spectrometry. Cancer Chemother Pharmacol 15:121 (10.1007/BF00257521) / Cancer Chemother Pharmacol by H Danigel (1985)
Douay L, Gorin NC, Mary IY, Lemarie E, Lopez M, Naiman A, Stachowiak I, Giarratana MC, Baillou C, Salmon F (1986) Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol 14:358 / Exp Hematol by L Douay (1986)
Finn GP, Bozek T, Souhami RL, Slevin ML, Thomas DGT (1985) High-dose etoposide in the treatment of relapsed primary brain tumors. Cancer Treat Rep 69:603 / Cancer Treat Rep by GP Finn (1985)
Gouyette A, Deniel A, Pico JL, Droz JP, Baume D, Ostronoff M, Le Bail N, Hayat M (1987) Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studies. Eur J Cancer Clin Oncol 23:1627 (10.1016/0277-5379(87)90441-X) / Eur J Cancer Clin Oncol by A Gouyette (1987)
Green JA, Tarpey AW, Warenius HM (1988) Pharmacokinetic study of high dose etoposide infusion in patients with small cell lung cancer. Acta Oncol 27:819 (10.3109/02841868809094365) / Acta Oncol by JA Green (1988)
Hande KR, Wedlund PJ, Noone RM, Wilkinson GR, Greco FA, Wolff SN (1984) Pharmacokinetic of high-dose etoposide (VP16-213) administered to cancer patients. Cancer Res 44:379 / Cancer Res by KR Hande (1984)
Holthuis JJM, Postmus PE, Van Oort PJ, Hulshoff B, Verleun H, Sleijfer DT, Mulder NH (1986) Pharmacokinetics of high dose etoposide (VP16-213). Eur J Cancer Clin Oncol 22:1149 (10.1016/0277-5379(86)90315-9) / Eur J Cancer Clin Oncol by JJM Holthuis (1986)
Jungclas H, Pflüger KH, Schmidt L, Hahn M (1989) Quantitative252Cf-PDMS for etoposide. J Phys Coll [C] 50 [Suppl 2]: 41 / J Phys Coll [C] by H Jungclas (1989)
Köppler H, Pflüger KH, Wolf M, Weide R, Havemann K (1990) High-dose chemotherapy with noncryopreserved autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. In: Büchner T, Schellong G, Hiddemann W, Ritter J (eds) Hematology and blood transfusion, vol 33. Acute leukemias II. Springer, Berlin Heidelberg New York, p 699 / Hematology and blood transfusion, vol 33. Acute leukemias II by H Köppler (1990)
Köppler H, Pflüger KH, Havemann H (1991) High-dose chemotherapy with autologous bone marrow rescue: hematopoietic reconstitution by non-cryopreserved bone marrow. Bone Marrow Transplant 7 [Suppl 2]: 143 / Bone Marrow Transplant by H Köppler (1991)
Loo JCK, Riegelmann S (1970) Assessment of pharmacokinetic constants from postinfusion blood curves obtained after i. v. infusion. J Pharm Sci 59:53 (10.1002/jps.2600590107) / J Pharm Sci by JCK Loo (1970)
Meloni G, De Fabritiis P, Carella AM (1990) Autologous bone marrow transplantation in patients with AML in first complete remission. Results of two different conditioning regimens after the same induction and consolidation therapy. Bone Marrow Transplant 5:29 / Bone Marrow Transplant by G Meloni (1990)
Newell DR, Eeles RA, Gumbrell LA, Boxall FE, Horwich A, Calvert AH (1989) Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma. Cancer Chemother Pharmacol 23:267 (10.1007/BF00435838) / Cancer Chemother Pharmacol by DR Newell (1989)
Newman EM, Doroshow JH, Forman SJ, Blume KG (1988) Pharmacokinetics of high-dose etoposide. Clin Pharmacol Ther 43:561 (10.1038/clpt.1988.73) / Clin Pharmacol Ther by EM Newman (1988)
Pflüger KH, Schmidt L, Merkel M, Jungclas H, Havemann K (1987) Drug monitoring of etoposide (VP16-213). Cancer Chemother Pharmacol 20:59 (10.1007/BF00252961) / Cancer Chemother Pharmacol by KH Pflüger (1987)
Postmus PE, De Vries EGE, De Vries-Hospers HG, Vriesendorp R, Van Imhoff GW, Holthuis JJM, Smit Sibinga CT, Sleijfer DT, Mulder NH (1984) Cyclophosphamide and VP16-213 with autologous bone marrow transplantation. A dose escalation study. Eur J Cancer Clin Oncol 20:777 (10.1016/0277-5379(84)90216-5) / Eur J Cancer Clin Oncol by PE Postmus (1984)
Schmitz N, Gassmann W, Rister M, Johannson W, Suttorp M, Brix F, Holthuis JJM, Heit W, Hertenstein B, Schaub J, Löffler H (1988) Fractionated total body irradiation and high-dose VP16-213 followed by allogeneic bone marrow transplantation in advanced leukemias. Blood 72:1567 (10.1182/blood.V72.5.1567.1567) / Blood by N Schmitz (1988)
Sinkule JA, Hutson P, Hayes FA, Etcubanas E, Evans W (1984) Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors. Cancer Res 44:3109 / Cancer Res by JA Sinkule (1984)
Spinilo JA, Dicke KA, Horwitz LJ (1990) Double intensification with amsacrine/high-dose ara-C and high-dose chemotherapy with autologous bone marrow transplantation produces durable remissions in acute myelogenous leukemia. Bone Marrow Transplant 5:111 / Bone Marrow Transplant by JA Spinilo (1990)
Spitzer G, Verma DS, Fisher R, Zander A, Vellekoop L, Litam J, McCredie KB, Dicke KA (1980) The myeloid progenitor cell?its value in predicting hematopoietic recovery after autologous bone marrow transplantation. Blood 55:317 (10.1182/blood.V55.2.317.317) / Blood by G Spitzer (1980)
Van Hoogenhuijze J, Lankelma J, Stam J, Pinedo HM (1987) Unchanged pharmacokinetics of VP16-213 (etoposide, NSC 141540) during concomitant administration of doxorubicin and cyclophosphamide. Eur J Cancer Clin Oncol 23:807 (10.1016/0277-5379(87)90283-5) / Eur J Cancer Clin Oncol by J Hoogenhuijze Van (1987)
Wolff SN, Fer MF, McKay CM, Hande KR, Hainsworth JD, Greco FA (1983) High-dose VP16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study. J Clin Oncol 1:701 (10.1200/JCO.1983.1.11.701) / J Clin Oncol by SN Wolff (1983)

Dates

Type	When
Created	20 years, 9 months ago (Nov. 28, 2004, 11:08 a.m.)
Deposited	2 years, 4 months ago (April 30, 2023, 10:57 a.m.)
Indexed	1 year, 11 months ago (Sept. 10, 2023, 6:58 a.m.)
Issued	33 years, 8 months ago (Jan. 1, 1992)
Published	33 years, 8 months ago (Jan. 1, 1992)
Published Print	33 years, 8 months ago (Jan. 1, 1992)

Funders 0

None

BibTeX

@article{K_hl_1992, title={Pharmacokinetics of high-dose etoposide after short-term infusion}, volume={29}, ISSN={1432-0843}, url={http://dx.doi.org/10.1007/bf00685951}, DOI={10.1007/bf00685951}, number={4}, journal={Cancer Chemotherapy and Pharmacology}, publisher={Springer Science and Business Media LLC}, author={K�hl, P. and K�ppler, H. and Schmidt, L. and Fritsch, H. W. and Holz, J. and Pfl�ger, K. H. and Jungclas, H.}, year={1992}, pages={316–320} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2023,
        9,
        10
      ]
    ],
    "date-time": "2023-09-10T10:58:01Z",
    "timestamp": 1694343481610
  },
  "reference-count": 25,
  "publisher": "Springer Science and Business Media LLC",
  "issue": "4",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1992,
            1,
            1
          ]
        ],
        "date-time": "1992-01-01T00:00:00Z",
        "timestamp": 694224000000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "http://www.springer.com/tdm"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1992
      ]
    ]
  },
  "DOI": "10.1007/bf00685951",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2004,
        11,
        28
      ]
    ],
    "date-time": "2004-11-28T16:08:57Z",
    "timestamp": 1101658137000
  },
  "page": "316-320",
  "source": "Crossref",
  "is-referenced-by-count": 16,
  "title": "Pharmacokinetics of high-dose etoposide after short-term infusion",
  "prefix": "10.1007",
  "volume": "29",
  "author": [
    {
      "given": "P.",
      "family": "K\ufffdhl",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "H.",
      "family": "K\ufffdppler",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "L.",
      "family": "Schmidt",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "H. W.",
      "family": "Fritsch",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "J.",
      "family": "Holz",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "K. H.",
      "family": "Pfl\ufffdger",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "H.",
      "family": "Jungclas",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "reference": [
    {
      "key": "CR1",
      "doi-asserted-by": "crossref",
      "first-page": "1015",
      "DOI": "10.1182/blood.V69.4.1015.1015",
      "volume": "69",
      "author": "KG Blume",
      "year": "1987",
      "unstructured": "Blume KG, Forman SJ, O'Donell MR, Doroshow JH, Krance RA, Nademanee AP, Snyder DS, Schmidt GM, Fahey JL, Metter GE, Hill LR, Findley DO, Sniecinski IJ (1987) Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood 69:1015",
      "journal-title": "Blood"
    },
    {
      "key": "CR2",
      "doi-asserted-by": "crossref",
      "first-page": "1068",
      "DOI": "10.1016/S0140-6736(84)91508-3",
      "volume": "11",
      "author": "AK Burnett",
      "year": "1984",
      "unstructured": "Burnett AK, Watkins R, Maharaj D (1984) Transplantation of unpurged autologous bone marrow in acute myeloid leukemia in first remission. Lancet 11:1068",
      "journal-title": "Lancet"
    },
    {
      "key": "CR3",
      "doi-asserted-by": "crossref",
      "first-page": "117",
      "DOI": "10.1007/BF02985449",
      "volume": "5",
      "author": "D Cunningham",
      "year": "1987",
      "unstructured": "Cunningham D, Cummings J, Blackie RB, McTaggart L, Banham SW, Kaye SB, Soukop M (1987) The pharmacokinetics of high dose cyclophosphamide and high dose etoposide. Med Oncol Tumor Pharmacother 5:117",
      "journal-title": "Med Oncol Tumor Pharmacother"
    },
    {
      "key": "CR4",
      "doi-asserted-by": "crossref",
      "first-page": "121",
      "DOI": "10.1007/BF00257521",
      "volume": "15",
      "author": "H Danigel",
      "year": "1985",
      "unstructured": "Danigel H, Pfl\u00fcger KH, Jungclas H, Schmidt L, Dellbr\u00fcgge J (1985) A combined method of liquid chromatography and mass spectrometry. Cancer Chemother Pharmacol 15:121",
      "journal-title": "Cancer Chemother Pharmacol"
    },
    {
      "key": "CR5",
      "first-page": "358",
      "volume": "14",
      "author": "L Douay",
      "year": "1986",
      "unstructured": "Douay L, Gorin NC, Mary IY, Lemarie E, Lopez M, Naiman A, Stachowiak I, Giarratana MC, Baillou C, Salmon F (1986) Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment. Exp Hematol 14:358",
      "journal-title": "Exp Hematol"
    },
    {
      "key": "CR6",
      "first-page": "603",
      "volume": "69",
      "author": "GP Finn",
      "year": "1985",
      "unstructured": "Finn GP, Bozek T, Souhami RL, Slevin ML, Thomas DGT (1985) High-dose etoposide in the treatment of relapsed primary brain tumors. Cancer Treat Rep 69:603",
      "journal-title": "Cancer Treat Rep"
    },
    {
      "key": "CR7",
      "doi-asserted-by": "crossref",
      "first-page": "1627",
      "DOI": "10.1016/0277-5379(87)90441-X",
      "volume": "23",
      "author": "A Gouyette",
      "year": "1987",
      "unstructured": "Gouyette A, Deniel A, Pico JL, Droz JP, Baume D, Ostronoff M, Le Bail N, Hayat M (1987) Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studies. Eur J Cancer Clin Oncol 23:1627",
      "journal-title": "Eur J Cancer Clin Oncol"
    },
    {
      "key": "CR8",
      "doi-asserted-by": "crossref",
      "first-page": "819",
      "DOI": "10.3109/02841868809094365",
      "volume": "27",
      "author": "JA Green",
      "year": "1988",
      "unstructured": "Green JA, Tarpey AW, Warenius HM (1988) Pharmacokinetic study of high dose etoposide infusion in patients with small cell lung cancer. Acta Oncol 27:819",
      "journal-title": "Acta Oncol"
    },
    {
      "key": "CR9",
      "first-page": "379",
      "volume": "44",
      "author": "KR Hande",
      "year": "1984",
      "unstructured": "Hande KR, Wedlund PJ, Noone RM, Wilkinson GR, Greco FA, Wolff SN (1984) Pharmacokinetic of high-dose etoposide (VP16-213) administered to cancer patients. Cancer Res 44:379",
      "journal-title": "Cancer Res"
    },
    {
      "key": "CR10",
      "doi-asserted-by": "crossref",
      "first-page": "1149",
      "DOI": "10.1016/0277-5379(86)90315-9",
      "volume": "22",
      "author": "JJM Holthuis",
      "year": "1986",
      "unstructured": "Holthuis JJM, Postmus PE, Van Oort PJ, Hulshoff B, Verleun H, Sleijfer DT, Mulder NH (1986) Pharmacokinetics of high dose etoposide (VP16-213). Eur J Cancer Clin Oncol 22:1149",
      "journal-title": "Eur J Cancer Clin Oncol"
    },
    {
      "issue": "Suppl 2",
      "key": "CR11",
      "first-page": "41",
      "volume": "50",
      "author": "H Jungclas",
      "year": "1989",
      "unstructured": "Jungclas H, Pfl\u00fcger KH, Schmidt L, Hahn M (1989) Quantitative252Cf-PDMS for etoposide. J Phys Coll [C] 50 [Suppl 2]: 41",
      "journal-title": "J Phys Coll [C]"
    },
    {
      "key": "CR12",
      "first-page": "699",
      "volume-title": "Hematology and blood transfusion, vol 33. Acute leukemias II",
      "author": "H K\u00f6ppler",
      "year": "1990",
      "unstructured": "K\u00f6ppler H, Pfl\u00fcger KH, Wolf M, Weide R, Havemann K (1990) High-dose chemotherapy with noncryopreserved autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. In: B\u00fcchner T, Schellong G, Hiddemann W, Ritter J (eds) Hematology and blood transfusion, vol 33. Acute leukemias II. Springer, Berlin Heidelberg New York, p 699"
    },
    {
      "issue": "Suppl 2",
      "key": "CR13",
      "first-page": "143",
      "volume": "7",
      "author": "H K\u00f6ppler",
      "year": "1991",
      "unstructured": "K\u00f6ppler H, Pfl\u00fcger KH, Havemann H (1991) High-dose chemotherapy with autologous bone marrow rescue: hematopoietic reconstitution by non-cryopreserved bone marrow. Bone Marrow Transplant 7 [Suppl 2]: 143",
      "journal-title": "Bone Marrow Transplant"
    },
    {
      "key": "CR14",
      "doi-asserted-by": "crossref",
      "first-page": "53",
      "DOI": "10.1002/jps.2600590107",
      "volume": "59",
      "author": "JCK Loo",
      "year": "1970",
      "unstructured": "Loo JCK, Riegelmann S (1970) Assessment of pharmacokinetic constants from postinfusion blood curves obtained after i. v. infusion. J Pharm Sci 59:53",
      "journal-title": "J Pharm Sci"
    },
    {
      "key": "CR15",
      "first-page": "29",
      "volume": "5",
      "author": "G Meloni",
      "year": "1990",
      "unstructured": "Meloni G, De Fabritiis P, Carella AM (1990) Autologous bone marrow transplantation in patients with AML in first complete remission. Results of two different conditioning regimens after the same induction and consolidation therapy. Bone Marrow Transplant 5:29",
      "journal-title": "Bone Marrow Transplant"
    },
    {
      "key": "CR16",
      "doi-asserted-by": "crossref",
      "first-page": "267",
      "DOI": "10.1007/BF00435838",
      "volume": "23",
      "author": "DR Newell",
      "year": "1989",
      "unstructured": "Newell DR, Eeles RA, Gumbrell LA, Boxall FE, Horwich A, Calvert AH (1989) Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma. Cancer Chemother Pharmacol 23:267",
      "journal-title": "Cancer Chemother Pharmacol"
    },
    {
      "key": "CR17",
      "doi-asserted-by": "crossref",
      "first-page": "561",
      "DOI": "10.1038/clpt.1988.73",
      "volume": "43",
      "author": "EM Newman",
      "year": "1988",
      "unstructured": "Newman EM, Doroshow JH, Forman SJ, Blume KG (1988) Pharmacokinetics of high-dose etoposide. Clin Pharmacol Ther 43:561",
      "journal-title": "Clin Pharmacol Ther"
    },
    {
      "key": "CR18",
      "doi-asserted-by": "crossref",
      "first-page": "59",
      "DOI": "10.1007/BF00252961",
      "volume": "20",
      "author": "KH Pfl\u00fcger",
      "year": "1987",
      "unstructured": "Pfl\u00fcger KH, Schmidt L, Merkel M, Jungclas H, Havemann K (1987) Drug monitoring of etoposide (VP16-213). Cancer Chemother Pharmacol 20:59",
      "journal-title": "Cancer Chemother Pharmacol"
    },
    {
      "key": "CR19",
      "doi-asserted-by": "crossref",
      "first-page": "777",
      "DOI": "10.1016/0277-5379(84)90216-5",
      "volume": "20",
      "author": "PE Postmus",
      "year": "1984",
      "unstructured": "Postmus PE, De Vries EGE, De Vries-Hospers HG, Vriesendorp R, Van Imhoff GW, Holthuis JJM, Smit Sibinga CT, Sleijfer DT, Mulder NH (1984) Cyclophosphamide and VP16-213 with autologous bone marrow transplantation. A dose escalation study. Eur J Cancer Clin Oncol 20:777",
      "journal-title": "Eur J Cancer Clin Oncol"
    },
    {
      "key": "CR20",
      "doi-asserted-by": "crossref",
      "first-page": "1567",
      "DOI": "10.1182/blood.V72.5.1567.1567",
      "volume": "72",
      "author": "N Schmitz",
      "year": "1988",
      "unstructured": "Schmitz N, Gassmann W, Rister M, Johannson W, Suttorp M, Brix F, Holthuis JJM, Heit W, Hertenstein B, Schaub J, L\u00f6ffler H (1988) Fractionated total body irradiation and high-dose VP16-213 followed by allogeneic bone marrow transplantation in advanced leukemias. Blood 72:1567",
      "journal-title": "Blood"
    },
    {
      "key": "CR21",
      "first-page": "3109",
      "volume": "44",
      "author": "JA Sinkule",
      "year": "1984",
      "unstructured": "Sinkule JA, Hutson P, Hayes FA, Etcubanas E, Evans W (1984) Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors. Cancer Res 44:3109",
      "journal-title": "Cancer Res"
    },
    {
      "key": "CR22",
      "first-page": "111",
      "volume": "5",
      "author": "JA Spinilo",
      "year": "1990",
      "unstructured": "Spinilo JA, Dicke KA, Horwitz LJ (1990) Double intensification with amsacrine/high-dose ara-C and high-dose chemotherapy with autologous bone marrow transplantation produces durable remissions in acute myelogenous leukemia. Bone Marrow Transplant 5:111",
      "journal-title": "Bone Marrow Transplant"
    },
    {
      "key": "CR23",
      "doi-asserted-by": "crossref",
      "first-page": "317",
      "DOI": "10.1182/blood.V55.2.317.317",
      "volume": "55",
      "author": "G Spitzer",
      "year": "1980",
      "unstructured": "Spitzer G, Verma DS, Fisher R, Zander A, Vellekoop L, Litam J, McCredie KB, Dicke KA (1980) The myeloid progenitor cell?its value in predicting hematopoietic recovery after autologous bone marrow transplantation. Blood 55:317",
      "journal-title": "Blood"
    },
    {
      "key": "CR24",
      "doi-asserted-by": "crossref",
      "first-page": "807",
      "DOI": "10.1016/0277-5379(87)90283-5",
      "volume": "23",
      "author": "J Hoogenhuijze Van",
      "year": "1987",
      "unstructured": "Van Hoogenhuijze J, Lankelma J, Stam J, Pinedo HM (1987) Unchanged pharmacokinetics of VP16-213 (etoposide, NSC 141540) during concomitant administration of doxorubicin and cyclophosphamide. Eur J Cancer Clin Oncol 23:807",
      "journal-title": "Eur J Cancer Clin Oncol"
    },
    {
      "key": "CR25",
      "doi-asserted-by": "crossref",
      "first-page": "701",
      "DOI": "10.1200/JCO.1983.1.11.701",
      "volume": "1",
      "author": "SN Wolff",
      "year": "1983",
      "unstructured": "Wolff SN, Fer MF, McKay CM, Hande KR, Hainsworth JD, Greco FA (1983) High-dose VP16-213 and autologous bone marrow transplantation for refractory malignancies: a phase I study. J Clin Oncol 1:701",
      "journal-title": "J Clin Oncol"
    }
  ],
  "container-title": "Cancer Chemotherapy and Pharmacology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/BF00685951.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/BF00685951/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/BF00685951",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        4,
        30
      ]
    ],
    "date-time": "2023-04-30T14:57:47Z",
    "timestamp": 1682866667000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/BF00685951"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1992
      ]
    ]
  },
  "references-count": 25,
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          1992
        ]
      ]
    }
  },
  "alternative-id": [
    "BF00685951"
  ],
  "URL": "http://dx.doi.org/10.1007/BF00685951",
  "relation": {},
  "ISSN": [
    "0344-5704",
    "1432-0843"
  ],
  "subject": [],
  "container-title-short": "Cancer Chemother. Pharmacol.",
  "published": {
    "date-parts": [
      [
        1992
      ]
    ]
  }
}